Loading...

First-in-Human Study of the Pharmacokinetics and Antiviral Activity of IDX375, a Novel Nonnucleoside Hepatitis C Virus Polymerase Inhibitor

IDX375 is a potent and selective palm-binding nonnucleoside inhibitor of the hepatitis C virus (HCV) genotype 1 polymerase. This first-in-human study evaluated the safety, tolerability, and pharmacokinetics of IDX375 in healthy volunteers, as well as its antiviral activity in HCV-infected patients....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: de Bruijne, J., van de Wetering de Rooij, J., van Vliet, A. A., Zhou, X. J., Temam, M. F., Molles, J., Chen, J., Pietropaolo, K., Sullivan-Bólyai, J. Z., Mayers, D., Reesink, H. W.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3421546/
https://ncbi.nlm.nih.gov/pubmed/22664976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00451-12
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!